International Conference on Gene Therapy Innovations and Delivery Mechanisms - (ICGTIDM-26)


26th - 27th October, 2026 | Markham, Canada

Multi-format (In-person/Virtual)

Submit for Presentation Attendee Registration Conference Brochure
Registration Options →

Explore conference registration categories designed for every mode of participation.

Home About Organizer Call For Paper Paper Submission Author Guidelines Registration Presentation Guidelines Organizing Committee Collaboration Agenda Do's and Dont's Invitation Letter Venue Contact Us

Important Dates

Pre-registration Deadline

26th September, 2026

Paper Submission Deadline

1st October, 2026

Last Date Of Registration

11th October, 2026

Date Of Conference

26th - 27th October, 2026

Downloads

Conference Flyer
Sample Abstract
Sample Full Paper

Call for Papers

The (ICGTIDM-26) is dedicated to advancing research excellence by bringing together leading scholars, scientists, and professionals from across the globe. It provides a platform for the dissemination of high-quality research and innovative methodologies.

With a strong focus on Genetics,Biology,Life Science, the conference promotes research that contributes to academic depth, practical insights, and interdisciplinary knowledge integration.

Authors are invited to submit papers addressing, but not limited to, the following areas:

  • Innovative gene delivery systems
  • CRISPR technology advancements
  • Gene therapy for rare diseases
  • Ethical considerations in gene therapy
  • Regulatory challenges in gene delivery
  • Patient perspectives on gene therapy
  • Long-term effects of gene therapy
  • Novel vectors for gene delivery
  • Gene therapy in pediatric populations
  • Clinical trials in gene therapy
  • Personalized gene therapy approaches
  • Combination therapies with gene editing
  • Impact of gene therapy on public health
  • Cost-effectiveness of gene therapies
  • Emerging technologies in gene delivery
  • Safety assessments in gene therapy
  • Gene therapy for genetic disorders
  • Public perception of gene therapy
  • Innovations in RNA-based therapies
  • Future directions in gene therapy

Peer Review Process

All submissions will be evaluated through a structured peer-review process to ensure academic rigor and contribution to the field. Accepted papers will be presented and may be considered for publication in high-quality journals and indexed conference proceedings.

Registration Details

Secure your participation by completing the registration process at the earliest. Limited presentation slots are allocated on a first-come, first-served basis.

Publication Opportunities

High-quality submissions will be prioritized for publication opportunities in recognized journals and indexed proceedings.

Submit Your Paper Today Register Early & Reserve Your Slot